Day: June 23, 2025

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and...

 Company announcement no. 31 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 33 44 00 00 23 June 2025 Page 1 of 1 Danske Bank share buy-back programme: transactions in week 25 On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025. The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions on Nasdaq Copenhagen...

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein. “CHMP’s...

Stockholm, June 23, 2025 – Virtune, the Swedish regulated crypto asset manager, celebrated the official launch of its latest exchange-traded product, the Virtune Coinbase 50 Index ETP, with a ceremonial bell ringing at Deutsche Börse Xetra in Frankfurt on June 17, together with Coinbase. The ceremony, held together with Coinbase, marks a significant milestone in Virtune’s European expansion and reinforces its position as a leading issuer of regulated, physically backed crypto ETPs. The product is available to Swedish investors via online brokers such as Avanza and Montrose. Virtune listed the product on Xetra on June 2, 2025, making the Virtune Coinbase 50 Index ETP the first ETP in Europe to track the Coinbase 50 Europe Index – a broadly diversified index representing up to 50 leading crypto assets. The index is developed by Coinbase...

The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 1,025.529 541.18 554,995,99516 June 2025 15,000 636.39 9,545,91917 June...

LEADING EDGE MATERIALS’ INVESTOR UPDATE ON SIGNIFICANT ACTIVITIES Vancouver, June 22, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) provides an investor update on significant activities. Overview – Becoming a European CRM producer Concerns about critical raw materials – security of supply, supply chain resilience and defence requirements – have been recurring themes at conferences attended by the Company in recent months, with Heavy Rare Earth Elements (“HREEs”) and natural graphite frequently mentioned; geopolitical uncertainty is the new norm and it is driving partnership, collaboration and greater levels of support for mining. On June 17, 2025, the G7 Critical Minerals Action Plan was announced focused on ‘diversifying the responsible...

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 23 June 2025 at 9.30 EEST         141,959 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 141,959 A shares have been converted into 141,959 B shares. The conversion has been entered into the Trade Register on 23 June 2025. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,308,783 A shares and 108,825,495 B shares. The number of votes of the company’s shares is after the conversion 755,001,155. Orion CorporationLiisa Hurme President and CEO     Mikko Kemppainen General Counsel  Contact person:Tuukka Hirvonen, Head of Investor Relations, tel. +358 10 426 2721                        ...

Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO AMSTERDAM, June 23, 2025 – Antonio Filosa today takes up the role as Chief Executive Officer of Stellantis N.V. and announces his new Stellantis Leadership Team, effective immediately, drawing on the deep bench of industry expertise from Stellantis’ teams around the world. “It is my great privilege to take the lead of Stellantis, a global company with deep regional roots,” said CEO Antonio Filosa. “We have unique strengths in our great people, our iconic brands and our millions of customers, whose loyalty to our Company, its fantastic products and its unique stories can only inspire us to new achievements.” The new appointments, which build on the organizational changes announced in February 2025, underline Stellantis’ breadth and depth of talent. The team structure...

Better than expected grades and widths from drilling in multiple areas anticipated to boost gold resources at Blanket ST HELIER, Jersey, June 23, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) is pleased to report further encouraging high grade results from the ongoing resource expansion drill programme at Caledonia’s 64% owned Blanket Mine. The programme is aimed at evaluating the continuity of the mineralised zones on the Blanket, Eroica and Lima orebodies (which comprise three of the main orebodies at Blanket Mine). The objectives of the programme are to increase the confidence levels of the existing mineral resource and to grow the mineral resource estimate below the 34 level of the mine (1,110 metres).  These results follow the previously announced results on January...